Related Experiment Video
Updated: Mar 16, 2026
03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
736
[EFFICIENCY OF EXTRAPLEURAL THORACOPLASTY WITH CAVERN LIGATION IN FIBROCAVERNOUS TUBERCULOSIS]
Tuberkulez I Bolezni Legkikh
|August 19, 2016
Summary
Supplementing extrapleural thoracoplasty with cavern ligation improves fibrocavernous tuberculosis treatment. This surgical approach leads to significant cavity closure and clinical resolution in most patients.
Area of Science:
- Medicine
- Pulmonology
- Infectious Diseases
Background:
- Fibrocavernous tuberculosis presents challenges in achieving complete lung collapse.
- Extrapleural thoracoplasty is a surgical option, but its efficiency can be improved.
Purpose of the Study:
- To evaluate the efficacy of supplementing extrapleural thoracoplasty with cavern ligation for fibrocavernous tuberculosis.
- To assess the impact of this combined surgical approach on cavity closure and patient outcomes.
Main Methods:
- A cohort of 164 patients with fibrocavernous tuberculosis underwent extrapleural thoracoplasty combined with cavern ligation.
- Caverns were primarily located in the upper lobes or upper lobes and sixth segments of the lungs.
Main Results:
- Decay cavity closure was achieved in 67.1% of patients.
- Bacterial excretion cessation was observed in 76.2% of evaluable patients.
- Long-term clinical resolution was reported in 83.7% of patients, with a 6.7% mortality rate.
Conclusions:
- Supplementing extrapleural thoracoplasty with cavern ligation is an effective method for treating fibrocavernous tuberculosis.
- The procedure's success is independent of cavern size but decreases with progressive tuberculous disease.
Related Concept Videos
01:27Pneumothorax-II
1.3K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.3K
01:28Pulmonary Tuberculosis V
730
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
730
01:28Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:26Pulmonary Tuberculosis IV
612
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612